Abbott Laboratories' EPS Up 12% On Emerging Market Strength
Sure Dividend • Yesterday, 11:50 AM
- Abbott Laboratories now generates more than 50% of revenue in emerging markets.
- The company has positioned its pharmaceutical segment exclusively in the developing world with recent divestitures and acquisitions.
- Abbott Laboratories has a 2% yield, fairly low payout ratio, and strong growth prospects ahead.